Tvardi Therapeutics Balance Sheet (2013-2026)

Reported Financials

Tvardi Therapeutics Quarterly Balance Sheet

Periods 54 quarters

Latest Jun 2026

Tvardi Therapeutics reported total assets of $17.52M and total liabilities of $9.13M for the quarter ended Jun 2026, down 60.0% year over year. This balance sheet covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation		1.16M				1.41M				1.67M
Receivables - AccuredAcc. Int. Receivables	0.32M	0.46M	0.44M	0.47M	0.45M	0.49M	0.49M	0.42M	0.23M	0.14M	0.16M	0.12M	0.10M	0.06M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	22.99M	13.45M	21.36M	46.72M	42.81M	63.74M	47.39M	58.25M	62.88M	51.77M	47.00M	49.24M	37.06M	31.61M	34.22M	20.65M	21.42M	20.73M	19.90M	15.80M
Receivables - NetNet Receivables	20.03M					3.26M			3.35M	2.77M	1.72M	0.36M	0.43M	0.41M	1.23M
Receivables - OtherOther Receivables	20.35M	0.46M	2.50M	8.00M	9.62M	0.50M	6.07M	10.12M	1.68M	0.56M	0.51M	0.76M	0.93M	4.09M	1.01M
Receivables	40.38M	0.46M				3.76M			5.03M	3.32M	2.22M	1.12M	1.37M	4.50M	2.24M
Raw Materials		0.93M	1.09M	1.82M	1.83M
Work In Process		1.66M	0.81M	0.64M	0.00M
Finished Goods				1.00M
Inventory		2.58M	1.91M	3.46M	1.83M	2.38M	3.52M	3.42M	3.27M	2.82M	2.74M	1.64M	0.62M	0.90M	0.90M
Prepaid Assets	6.26M	2.52M	5.11M	6.03M	18.56M	16.27M	17.20M	14.98M	12.66M	8.15M	5.79M	3.78M	2.38M	0.07M	1.59M	2.14M	1.98M	0.73M	0.34M	1.30M
Current Assets	171.50M	173.29M	151.76M	176.17M	186.78M	168.91M	142.66M	124.74M	100.60M	116.16M	81.22M	63.86M	47.91M	31.69M		43.13M	38.44M	31.54M	25.33M	17.07M
Non-Current Assets
Property, Plant & Equipment (Net)	0.65M	0.63M	0.61M	0.55M	0.49M	0.43M	0.37M	0.31M	1.38M	3.32M	3.55M	3.49M	3.42M	0.08M		0.07M	0.06M	0.05M	0.04M	0.04M
Long-Term Investments	49.22M	69.75M	68.46M	47.17M	23.92M	11.35M	9.07M	7.05M	4.75M
Intangibles														0.39M		0.35M	0.34M	0.32M	0.31M	0.29M
Goodwill & Intangibles														0.39M		0.35M	0.34M	0.32M	0.31M	0.29M
Other Non-Current Assets	0.41M	0.41M	0.41M	0.41M	0.41M			1.50M	1.50M	1.50M	1.50M	1.50M		2.81M		0.02M	0.02M	0.02M	0.02M	0.02M
Non-Current Assets	53.59M	73.77M	72.10M	50.41M	26.73M	13.33M	10.62M	9.65M	14.73M	9.69M	8.87M	8.64M	3.42M	3.51M		0.62M	0.58M	0.54M	0.49M	0.45M
Assets	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M	25.82M	17.52M
Liabilities
Current Liabilities
Accounts Payables	13.81M	15.86M	16.50M	19.33M	26.32M	21.54M	15.22M	24.48M	22.38M	25.59M	14.88M	13.73M	6.62M	2.19M	1.20M	2.42M	4.08M	3.22M	4.62M	4.64M
Payables	13.81M	15.86M	16.50M	19.33M	26.32M	21.54M	15.22M	24.48M	22.38M	25.59M	14.88M	13.73M	6.62M	2.19M	1.20M	2.42M	4.08M	3.22M	4.62M	4.64M
Accumulated Expenses														8.08M		8.14M	6.85M	7.71M	6.52M	4.35M
Other Accumulated Expenses														0.01M		0.45M	0.45M	0.32M	0.18M	0.06M
Current Deferred Revenue
Total Current Liabilities	15.53M	17.62M	18.30M	21.17M	28.19M	23.46M	16.68M	25.46M	22.88M	25.59M	15.10M	13.90M	10.04M	10.37M	1.20M	10.68M	11.04M	11.04M	11.26M	9.11M
Non-Current Liabilities
Convertible Debt														30.26M
Non-Current Deffered Revenue
Preferred Stock Liabilities										85.50M	85.50M	85.50M	85.50M	85.50M	85.50M
Operating Leases	2.37M	1.92M	1.46M	0.98M	0.50M				6.82M	6.09M	6.83M	7.32M		0.20M		0.14M	0.12M	0.09M	0.05M	0.02M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities	17.90M	19.53M	19.75M	22.15M	28.69M	23.46M	16.68M	25.46M	29.70M	187.90M	156.27M	145.56M	129.83M	126.33M	139.57M	10.82M	11.15M	11.13M	11.31M	9.13M
Shareholder's Equity
Common Equity	207.19M	227.52M	204.12M	204.42M	184.82M	158.78M	136.60M	108.93M	85.64M	-62.06M	-66.17M	-73.07M	-78.50M	-91.13M	-100.62M	32.93M	27.87M	20.95M	14.51M	8.38M
Liabilities and Shareholders Equity	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M	25.82M	17.52M
Retained Earnings	-447.38M	-480.76M	-508.51M	-512.71M	-535.89M	-566.23M	-592.90M	-624.38M	-652.41M	-684.75M	-715.44M	-735.46M	-747.93M	-92.24M	-760.52M	-97.65M	-103.20M	-110.45M	-117.30M	-123.71M

Tvardi Therapeutics Balance Sheet API

Pull Tvardi Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TVRD&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "TVRD", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=TVRD&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Tvardi Therapeutics TVRD Balance Sheet (2013-2026)

Tvardi Therapeutics Quarterly Balance Sheet

Tvardi Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password